Predicted to enable cysteine-type deubiquitinase activity. Involved in anterior/posterior axis specification, embryo. Located in cytoplasm. Expressed in germ line. Is an ortholog of human USP47 (ubiquitin specific peptidase 47).
Enables cysteine-type deubiquitinase activity and ionotropic glutamate receptor binding activity. Involved in anterior/posterior axis specification, embryo; positive regulation of gene expression; and positive regulation of locomotion involved in locomotory behavior. Located in endosome and neuronal cell body. Expressed in body wall musculature; intestine; nervous system; pharynx; and vulval muscle. Is an ortholog of human USP46 (ubiquitin specific peptidase 46).
Predicted to enable cysteine-type deubiquitinase activity and proteasome binding activity. Predicted to be involved in protein deubiquitination and regulation of proteasomal protein catabolic process. Predicted to be part of proteasome complex. Is an ortholog of human USP14 (ubiquitin specific peptidase 14).
Predicted to enable G protein-coupled receptor activity. Involved in G protein-coupled receptor signaling pathway and egg-laying behavior. Predicted to be located in axon; membrane; and somatodendritic compartment. Expressed in HSNL; HSNR; PVQL; PVQR; and vulva.
Predicted to enable carbohydrate binding activity. Involved in response to gamma radiation. Predicted to be located in external side of plasma membrane.
Predicted to enable glycine transmembrane transporter activity. Predicted to be involved in gamma-aminobutyric acid transport; glycine transport; and neurotransmitter loading into synaptic vesicle. Located in synaptic vesicle. Expressed in neurons. Used to study alcohol use disorder. Human ortholog(s) of this gene implicated in generalized epilepsy with febrile seizures plus. Is an ortholog of human SLC32A1 (solute carrier family 32 member 1).
Is affected by several genes including hsf-1; prg-1; and alg-1 based on RNA-seq studies. Is affected by four chemicals including nicotine; multi-walled carbon nanotube; and Microcystin-LR based on quantitative PCR; RNA-seq; and microarray studies.